menu
    • menu

    Company profile for Harrow

    NEW Drugs in Dev: 8
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Harrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is directly tied to our unique approach to serving patients and supporting eyecare professionals. We make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, ...
    Harrow is a growing leader in the ophthalmic healthcare market. Our success-to-date is directly tied to our unique approach to serving patients and supporting eyecare professionals. We make pharmaceutical products for the over 8 million annual ophthalmic surgeries in the U.S., as well as medications prescribed to treat patients managing chronic and acute eye conditions such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions. We serve over 10,000 doctors, hospitals, and ambulatory service centers (ASCs) and regularly ship to over 1,500 institutional accounts each month.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HarrowUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    102 Woodmont Blvd., Suite 610 Nashville, TN 37205
    Telephone
    Telephone
    (615) 733 4730
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.harrowinc.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/harrow-health-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Harrow Announces First Quarter 2026 Financial Results
    Harrow Announces First Quarter 2026 Financial Results

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292306/0/en/harrow-announces-first-quarter-2026-financial-results.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Harrow To Report Q1 2026 Financial Results On May 11, 2026
    Harrow To Report Q1 2026 Financial Results On May 11, 2026

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281477/0/en/harrow-to-report-first-quarter-2026-financial-results-after-market-close-on-may-11-2026.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Harrow Announces The Issuance Of J-Code For IOPIDINE 1%
    Harrow Announces The Issuance Of J-Code For IOPIDINE 1%

    16 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/16/3275180/0/en/Harrow-Announces-the-Issuance-of-J-Code-for-IOPIDINE-1.html

    GLOBENEWSWIRE
    16 Apr 2026
    Share Share
    Harrow Initiates $50M Senior Unsecured Notes Offering For Growth
    Harrow Initiates $50M Senior Unsecured Notes Offering For Growth

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261202/0/en/Harrow-Announces-Add-On-Offering-of-50-0-Million-of-Senior-Unsecured-Notes-to-Support-Growth.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Harrow Prices $50M Senior Unsecured Notes Offering Due 2030
    Harrow Prices $50M Senior Unsecured Notes Offering Due 2030

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261806/0/en/Harrow-Announces-Pricing-of-50-0-Million-Offering-of-Senior-Unsecured-Notes-Due-2030.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    Harrow To Present Three Abstracts At ASCRS 2026 Meeting
    Harrow To Present Three Abstracts At ASCRS 2026 Meeting

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258016/0/en/Harrow-Announces-Three-Abstracts-Accepted-for-Presentation-at-ASCRS-2026-Annual-Meeting.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search